Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure*
暂无分享,去创建一个
K. Shimamoto | Y. Horio | S. Ishikawa | T. Miura | A. Kuno | T. Yano | M. Tanno | S. Hisahara
[1] Gene Kim,et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. , 2009, The Journal of clinical investigation.
[2] K. Birukov,et al. SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1 , 2009, Molecular and Cellular Biology.
[3] Makoto Sato,et al. Histone deacetylase SIRT1 modulates neuronal differentiation by its nuclear translocation , 2008, Proceedings of the National Academy of Sciences.
[4] J. Brotchie,et al. Dietary resveratrol administration increases MnSOD expression and activity in mouse brain. , 2008, Biochemical and biophysical research communications.
[5] Amy V. Lynch,et al. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes , 2007, Nature.
[6] Q. Zhai,et al. SIRT1 improves insulin sensitivity under insulin-resistant conditions by repressing PTP1B. , 2007, Cell metabolism.
[7] S. Vatner,et al. Sirt1 Regulates Aging and Resistance to Oxidative Stress in the Heart , 2007, Circulation research.
[8] Stefan Neubauer,et al. The failing heart--an engine out of fuel. , 2007, The New England journal of medicine.
[9] K. Shimamoto,et al. Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1* , 2007, Journal of Biological Chemistry.
[10] Yunyu Zhang,et al. Protective effects of exercise and phosphoinositide 3-kinase(p110α) signaling in dilated and hypertrophic cardiomyopathy , 2007, Proceedings of the National Academy of Sciences.
[11] P. Puigserver,et al. Resveratrol Improves Mitochondrial Function and Protects against Metabolic Disease by Activating SIRT1 and PGC-1α , 2006, Cell.
[12] L. Guarente,et al. Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction. , 2006, Genes & development.
[13] Jiandie D. Lin,et al. Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators , 2006, Cell.
[14] Brian K. Kennedy,et al. Sirtuins in Aging and Age-Related Disease , 2006, Cell.
[15] S. Marklund,et al. Phenotypes of Mice Lacking Extracellular Superoxide Dismutase and Copper- and Zinc-containing Superoxide Dismutase* , 2006, Journal of Biological Chemistry.
[16] S. Imai,et al. Poly(ADP-ribose) Polymerase-1-dependent Cardiac Myocyte Cell Death during Heart Failure Is Mediated by NAD+ Depletion and Reduced Sir2α Deacetylase Activity* , 2005, Journal of Biological Chemistry.
[17] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[18] Wilhelm Haas,et al. Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1 , 2005, Nature.
[19] Frank J Giordano,et al. Oxygen, oxidative stress, hypoxia, and heart failure. , 2005, The Journal of clinical investigation.
[20] G. Dorn,et al. Protein kinase cascades in the regulation of cardiac hypertrophy. , 2005, The Journal of clinical investigation.
[21] Robert S. Balaban,et al. Mitochondria, Oxidants, and Aging , 2005, Cell.
[22] C. Epstein,et al. CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life , 2005, Oncogene.
[23] D. Conte,et al. The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis , 2004, Journal of Medical Genetics.
[24] S. Vatner,et al. Silent Information Regulator 2&agr;, a Longevity Factor and Class III Histone Deacetylase, Is an Essential Endogenous Apoptosis Inhibitor in Cardiac Myocytes , 2004, Circulation research.
[25] R. Medema,et al. FOXO4 Is Acetylated upon Peroxide Stress and Deacetylated by the Longevity Protein hSir2SIRT1* , 2004, Journal of Biological Chemistry.
[26] Satoko Aratani,et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[27] Phuong Chung,et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan , 2003, Nature.
[28] F. Alt,et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] P. Lansdorp,et al. The Mammalian SIR2α Protein Has a Role in Embryogenesis and Gametogenesis , 2003, Molecular and Cellular Biology.
[30] S. Silver,et al. Heart Failure , 1937, The New England journal of medicine.
[31] Geert J. P. L. Kops,et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress , 2002, Nature.
[32] Ian L. Rogers,et al. Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. , 1999, Molecular pharmacology.
[33] Y. Murakami,et al. Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. S. St. Clair,et al. The protective role of manganese superoxide dismutase against adriamycin-induced acute cardiac toxicity in transgenic mice. , 1996, The Journal of clinical investigation.
[35] C. Epstein,et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase , 1995, Nature Genetics.
[36] S. Renaud,et al. Wine, alcohol, platelets, and the French paradox for coronary heart disease , 1992, The Lancet.